BlackRock Institutional Trust’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Institutional Trust’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$26M	Buy	1,248,310 +127,224	+11%	+$3.31M	﹤0.01%	1778
2016 Q3	$36.7M	Buy	1,121,086 +59,174	+6%	+$1.8M	0.01%	1476
2016 Q2	$26.5M	Buy	1,061,912 +460,322	+77%	+$12.5M	﹤0.01%	1659
2016 Q1	$14.7M	Buy	601,590 +1,782	+0.3%	+$41.3K	﹤0.01%	2013
2015 Q4	$19.8M	Buy	599,808 +10,999	+2%	+$372K	﹤0.01%	1873
2015 Q3	$19.3M	Buy	588,809 +263,742	+81%	+$11.2M	﹤0.01%	1865
2015 Q2	$17.2M	Buy	325,067 +117,242	+56%	+$4.26M	﹤0.01%	2027
2015 Q1	$6M	Buy	207,825 +69,264	+50%	+$1.9M	﹤0.01%	2689
2014 Q4	$4.03M	Sell	138,561 -607	-0.4%	-$10.9K	﹤0.01%	2813
2014 Q3	$1.76M	Sell	139,168 -15,281	-10%	-$231K	﹤0.01%	3132
2014 Q2	$3.1M	Buy	+154,449	New	+$2.17M	﹤0.01%	2997

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock Institutional Trust's ALDR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Alder Biopharmaceuticals (ALDR) stake by 11% in Q4 2016, buying an estimated $3.31M and bringing the position to 1,248,310 shares worth $26M. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

BlackRock Institutional Trust first reported a position in ALDR in Q2 2014 and has held it in 11 quarters since. The position peaked at $36.7M in Q3 2016. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Institutional Trust held 1,248,310 shares of Alder Biopharmaceuticals worth $26M as of Q4 2016.
BlackRock Institutional Trust bought 127,224 Alder Biopharmaceuticals shares in Q4 2016, an estimated $3.31M.
Alder Biopharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1778 holding.
BlackRock Institutional Trust first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Institutional Trust's Alder Biopharmaceuticals position peaked at $36.7M in Q3 2016.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.